FCR is a combination treatment used to treat chronic lymphocytic leukaemia (CLL) and some types of non-Hodgkin lymphoma (NHL). It is best to read this information with our general information about chemotherapy and the type of cancer you have.
FCR comes from the initials of the drugs used:
Rituximab is not a chemotherapy drug. It is a monoclonal antibody.